Research in my laboratory is focused to better understand how metabolic reprogramming regulates platelet and leukocyte function and whether targeting enzymes involved in aerobic glycolysis can inhibit thrombo-inflammation. If successful, this could be developed as a therapeutic strategy toward better management of patients at high risk for acute coronary events and stroke. We utilize state-of-the-art imaging techniques like intravital microscopy, laser-speckle imaging and magnetic resonance imaging in order to study mechanistic role of thrombo-inflammation in the modulation of acute ischemic stroke and thrombosis. In addition, research projects use molecular and cellular techniques, combined with genetically modified mice to investigate the role of novel molecules in the pathophysiology of atherosclerosis and neointimal hyperplasia.
Learn more about our research.
Recent News
Dr. Manasa Nayak receives a 2022 ATVB Scientific Sessions Travel Grant for Early Career Investigators (September 2022)
Dr. Anil K. Chauhan is named Director of Thrombosis and Vascular Biology (June 2022)
Dr. Manasa Nayak receives AHA career development award (March 2022)
Dr. Anil K. Chauhan is named to Distinguished Scholar Program (February 2022)
Dr. Gagan Flora receives two-year $140,952 AHA postdoctoral award (December 2021)
Dr. Mariia Kumskova receives NHF early career seed grant (October 2021)
Dr. Manasa Nayak promoted to Research Assistant Professor of Internal Medicine (July 2021)
Funding Sources
